PCVX News & Events

The deal size was increased to $550M in common stock from $500M in common stock. BofA, Jefferies, Leerink, Evercore ISI and Guggenheim acted as joint book running managers for the offering.

BofA Securities, Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering.

Vaxcyte offering marketed at $50 per share, Bloomberg says

Vaxcyte announced that it has commenced an underwritten public offering of $500M of its common stock and pre-funded warrants. All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Vaxcyte. BofA Securities, Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering.